Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DAP000510

Drug Information
NameMoricizine
SynonymsEthyl (10-(3-(4-morpholinyl)-1-oxopropyl)-10H-phenothiazin-2-yl)carbamate; EINECS 250-854-5; Moricizine (USAN); CID34633; AC1L1RZ3; Oprea1_701257; Moracizine; UNII-2GT1D0TMX1; EN-313; MLS001201823; BRD-K21548250-003-03-5; Moricizine [USAN]; AC1Q35C0; LS-50419; C22H25N3O4S; DB00680; MORICIZINE; Moracizine (INN); BIDD:GT0499; ethyl N-[10-(3-morpholin-4-ylpropanoyl)phenothiazin-2-yl]carbamate; ethyl [10-(3-morpholin-4-ylpropanoyl)-10H-phenothiazin-2-yl]carbamate; BAS 01947592; Moracizinum [INN-Latin]; STOCK1S-27850; Ethyl 10-(3-morpholinopropionyl)phenothiazine-2-carbamate; Oprea1_682904; MolPort-001-727-947; ethyl {10-[3-(morpholin-4-yl)propanoyl]-10H-phenothiazin-2-yl}carbamate; ethyl 10-(beta-N-morpholinylpropionyl)phenothiazine-2-carbamate; Moracizinum; NCGC00016809-01; Carbamic acid, (10-(3-(4-morpholinyl)-1-oxopropyl)-10H-phenothiazin-2-yl)-, ethyl ester; NCGC00074074-03; ZINC19340795; ethyl N-{10-[3-(morpholin-4-yl)propanoyl]-10H-phenothiazin-2-yl}carbamate; Moracizina; Phenothiazine-2-carbamic acid, 10-(3-morpholinopropionyl)-, ethyl ester; BPBio1_001104; G 214; Prestwick2_001051; TimTec1_000772; AB00514710; SPBio_002931; CHEMBL1075; STK370502; HMS1536D02; AKOS001487682; AC1Q35BY; 31883-05-3; CAS-31883-05-3; SMR000059585; CBDivE_008814; Prestwick3_001051; Moracizin; AC1Q65LI; C07743; Prestwick1_001051; Prestwick0_001051; CHEBI:6997; D05077; Moracizina [INN-Spanish]; BSPBio_001002
IndicationIrregular heartbeats
[ICD9: 427   ICD10: I47-I49]
Approved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C22H25N3O4S/c1-2-29-22(27)23-16-7-8-20-18(15-16)25(17-5-3-4-6-
19(17)30-20)21(26)9-10-24-11-13-28-14-12-24/h3-8,15H,2,9-14H2,1H3
,(H,23,27)
InChIKeyFUBVWMNBEHXPSU-UHFFFAOYSA-N
Canonical SMILESCCOC(=O)NC1=CC2=C(C=C1)SC3=CC=CC=C3N2C(=O)CCN4CCOCC4    
Therapeutic ClassAnti-Arrhythmia Agents
CAS NumberCAS 31883-05-3
FormulaC22H25N3O4S
PubChem Compound IDCID 34633.
PubChem Substance IDSID 9945.
SuperDrug ATC IDC01BG01
SuperDrug CAS ID031883053;
TargetSodium channel protein type 5 subunit alphaBlocker[2]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 019753 To Reference
Ref 2From first class to third class: recent upheaval in antiarrhythmic therapy--lessons from clinical trials. Am J Cardiol. 1996 Aug 29;78(4A):28-33. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543